Publikace
- Cell Based Therapy for Type 1 Diabetes: Should We Take Hyperglycemia Into Account?2019 | 2. lékařská fakulta
- Tolerogenní dendritické buňky a jejich využití v léčbě imunopatologických stavů2017 | 2. lékařská fakulta
- Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms2020 | 2. lékařská fakulta
- Tolerogenic Dendritic Cells from Poorly Compensated Type 1 Diabetes Patients Have Decreased Ability To Induce Stable Antigen-Specific T Cell Hyporesponsiveness and Generation of Suppressive Regulatory T Cells2017 | 2. lékařská fakulta
- NF-kappa B, p38 MAPK, ERK1/2, mTOR, STAT3 and increased glycolysis regulate stability of paricalcitol/dexamethasone-generated tolerogenic dendritic cells in the inflammatory environment2015 | 2. lékařská fakulta
Loading network view...